Ross is a partner in the Corporate Technology team, based in our Cambridge office.

Ross’s practice focuses on helping tech and life sciences companies in all aspects of their growth, capital raising and international expansion. He has extensive experience of a variety of venture financing and public capital raisings, mergers and acquisitions and general corporate advice, with a particular specialism in transactions with a transatlantic component.

Ross has extensive experience of transactions involving the US and was based out of San Francisco, CA in 2018 - 19. As a result, he has a particular expertise in supporting US investors and companies in their investment into the UK and elsewhere, as well as counselling UK companies looking to take investment from, or exit to, the US. He is an English qualified solicitor and registered foreign legal consultant in California.

Ross is the co-author of PLC’s leading article on M&A pricing structures: Pricing Mechanisms: locked box vs completion accounts.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies

16 février 2021

par Ross McNaughton et Colin McCall

Cliquer ici pour en savoir plus
Technologie, Médias et Communications (TMC)

Investment round for Cambridge quantum computing company

10 février 2021

par Ross McNaughton et Alex Dodds

Cliquer ici pour en savoir plus
Technologie, Médias et Communications (TMC)

Advising Oxbotica in $47 million Series B investment

15 janvier 2021

par Ross McNaughton et Matt Harrison

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Topia on $15 million venture loan facility

28 octobre 2020

par Ross McNaughton

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser